Related references
Note: Only part of the references are listed.The epigenetics of prostate cancer diagnosis and prognosis: update on clinical applications
Michael L. Blute et al.
CURRENT OPINION IN UROLOGY (2015)
Epigenetic biomarkers in prostate cancer: Current and future uses
Karen Chiam et al.
CANCER LETTERS (2014)
Prognostic DNA Methylation Markers for Prostate Cancer
Siri H. Strand et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Transcriptional activity of heparan sulfate biosynthetic machinery is specifically impaired in benign prostate hyperplasia and prostate cancer
Anastasia V. Suhovskih et al.
FRONTIERS IN ONCOLOGY (2014)
Methylation markers for prostate cancer prognosis: a systematic review
Chun Chao et al.
CANCER CAUSES & CONTROL (2013)
Genomic Profiling Defines Subtypes of Prostate Cancer with the Potential for Therapeutic Stratification
Jamie R. Schoenborn et al.
CLINICAL CANCER RESEARCH (2013)
Absolute Quantitation of DNA Methylation of 28 Candidate Genes in Prostate Cancer Using Pyrosequencing
Nataڑa Vasiljeviš et al.
DISEASE MARKERS (2013)
DNA Methylation Signatures for Prediction of Biochemical Recurrence After Radical Prostatectomy of Clinically Localized Prostate Cancer
Christa Haldrup et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
A Three-Marker FISH Panel Detects More Genetic Aberrations of AR, PTEN and TMPRSS2/ERG in Castration-Resistant or Metastatic Prostate Cancers than in Primary Prostate Tumors
Xiaoyu Qu et al.
PLOS ONE (2013)
Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia
J. M. Devaney et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2013)
A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancer
Xiaoyu Qu et al.
CANCER GENETICS (2013)
The OPCML Tumor Suppressor Functions as a Cell Surface Repressor-Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer
Arthur B. McKie et al.
CANCER DISCOVERY (2012)
Mouse FLRT2 Interacts with the Extracellular and Intracellular Regions of FGFR2
K. Wei et al.
JOURNAL OF DENTAL RESEARCH (2011)
The role of FGF/Erk signaling in pluripotent cells
Fredrik Lanner et al.
DEVELOPMENT (2010)
Concepts of epigenetics in prostate cancer development
C. S. Cooper et al.
BRITISH JOURNAL OF CANCER (2009)
Epigenetic Alterations in Human Prostate Cancers
William G. Nelson et al.
ENDOCRINOLOGY (2009)
Gleason Score and Lethal Prostate Cancer: Does 3+4=4+3?
Jennifer R. Stark et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts
Akiko Doi et al.
NATURE GENETICS (2009)
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
Rafael A. Irizarry et al.
NATURE GENETICS (2009)
Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype
I. Van der Auwera et al.
BRITISH JOURNAL OF CANCER (2008)
Management of complications of prostate cancer treatment
M. Dror Michaelson et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
DNA Hypomethylation Arises Later in Prostate Cancer Progression than CpG Island Hypermethylation and Contributes to Metastatic Tumor Heterogeneity
Srinivasan Yegnasubramanian et al.
CANCER RESEARCH (2008)
The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells
Anne Myrthue et al.
CLINICAL CANCER RESEARCH (2008)
Comprehensive high-throughput arrays for relative methylation (CHARM)
Rafael A. Irizarry et al.
GENOME RESEARCH (2008)
OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation
Yan Cui et al.
PLOS ONE (2008)
Regulated expression of FLRT genes implies a functional role in the regulation of FGF signalling during mouse development
Bryan P. Haines et al.
DEVELOPMENTAL BIOLOGY (2006)
Nomograms for prostate cancer
Andrew J. Stephenson et al.
BJU INTERNATIONAL (2006)
The transmembrane protein XFLRT3 forms a complex with FGF receptors and promotes FGF signalling
RT Bottcher et al.
NATURE CELL BIOLOGY (2004)
Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells
S Ropero et al.
HUMAN MOLECULAR GENETICS (2004)
Restoration of fibroblast growth factor receptor2 suppresses growth and tumorigenicity of malignant human prostate carcinoma PC-3 cells
H Yasumoto et al.
PROSTATE (2004)
OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer
GC Sellar et al.
NATURE GENETICS (2003)
An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein
RP Carstens et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
